Related references
Note: Only part of the references are listed.Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Xiao-Feng Li et al.
NATURE COMMUNICATIONS (2018)
Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
Miguel A. Martin-Acebes et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
An update on Zika vaccine developments
Anna Durbin et al.
EXPERT REVIEW OF VACCINES (2017)
Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue
Scott B. Halstead
LANCET INFECTIOUS DISEASES (2017)
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis
Franz X. Heinz et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
Chao Shan et al.
NATURE MEDICINE (2017)
Zika Virus Infection and Associated Neurologic Disorders in Brazil
Wanderson K. de Oliveira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis
Xuping Xie et al.
MBIO (2017)
New reverse genetics and transfection methods to rescue arboviruses in mosquito cells
Therese Atieh et al.
SCIENTIFIC REPORTS (2017)
Emerging arboviruses: Why today?
Ernest Gould et al.
ONE HEALTH (2017)
Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice
Annie Elong Ngono et al.
CELL HOST & MICROBE (2017)
A Mouse Model of Zika Virus Pathogenesis
Helen M. Lazear et al.
CELL HOST & MICROBE (2016)
Towards antiviral therapies for treating dengue virus infections
Suzanne J. F. Kaptein et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
Lesley J. Scott
DRUGS (2016)
Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas
Qing Ye et al.
INFECTION GENETICS AND EVOLUTION (2016)
Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
Van-Mai Cao-Lormeau et al.
LANCET (2016)
Vaccine protection against Zika virus from Brazil
Rafael A. Larocca et al.
NATURE (2016)
Zika virus infection damages the testes in mice
Jennifer Govero et al.
NATURE (2016)
The 3.8 Å resolution cryo-EM structure of Zika virus
Devika Sirohi et al.
SCIENCE (2016)
How Did Zika Virus Emerge in the Pacific Islands and Latin America?
John H. -O. Pettersson et al.
MBIO (2016)
The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection
L. Delang et al.
SCIENTIFIC REPORTS (2016)
Simple reverse genetics systems for Asian and African Zika viruses
Therese Atieh et al.
SCIENTIFIC REPORTS (2016)
Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets
Daniela Weiskopf et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Live virus vaccines based on a yellow fever vaccine backbone: Standardized template with key considerations for a risk/benefit assessment
Thomas P. Monath et al.
VACCINE (2015)
Live attenuated vaccines: Historical successes and current challenges
Philip D. Minor
VIROLOGY (2015)
The Human CD8(+) T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
Daniela Weiskopf et al.
JOURNAL OF VIROLOGY (2015)
ISA-Lation of Single-Stranded Positive-Sense RNA Viruses from Non-Infectious Clinical/Animal Samples
Fabien Aubry et al.
PLOS ONE (2015)
Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons
Fabien Aubry et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Wolbachia Influences the Maternal Transmission of the gypsy Endogenous Retrovirus in Drosophila melanogaster
Franck Touret et al.
MBIO (2014)
Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine
Ruth Chin et al.
INFECTIOUS DISEASES AND THERAPY (2013)
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
P. Noel Barrett et al.
EXPERT REVIEW OF VACCINES (2009)
Zika Virus Outbreak on Yap Island, Federated States of Micronesia
Mark R. Duffy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection
Kathleen C. F. Sheehan et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
High fidelity of yellow fever virus RNA polymerase
KV Pugachev et al.
JOURNAL OF VIROLOGY (2004)
ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy
J Arroyo et al.
JOURNAL OF VIROLOGY (2004)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
KJ Blight et al.
JOURNAL OF VIROLOGY (2002)
Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: Relevance to development and safety testing of live, attenuated vaccines
TP Monath et al.
JOURNAL OF VIROLOGY (2002)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Share Paper
